During a Lise-Meitner-Program research project, bioassay-guided fractionation of species
belonging to Clusiaceae (Mammey Apple Family) was conducted to isolate new bioactive
substances. Several species of Hypericum L. (St. John's Wort) have records of traditional use in topical applications for reducing
inflammation and wound-healing [1]. Therefore, lipophilic extracts of 9 species of
Hypericum (all belonging to tribe Hypericeae) were examined. In addition, lipophilic extracts
from Triadenum walterii (tribe Hypericeae) and Clusia valerioi (tribe Clusieae) were studied. Results of anti-inflammatory bioassays for several
isolated compounds against COX-1, COX-2, and 5-LOX, enzymes implicated in inflammation
response, indicated that a new phloroglucinol derivative (1) from H. lissophloeus had the highest activity against COX-1 (IC50 9.5 uM) and a known xanthone (2) and phloroglucinol derivative (3) from H. canariense displayed the highest activity against COX-2 (IC50 16.9 uM) and 5-LOX (IC50 0.3 uM), respectively.
Acknowledgements: Thanks go to Dr. Wolfgang M. Schühly for help collecting material of several Hypericum species in the field in the southeastern United States. Katrina Dlugosch (University
of California, Santa Cruz) is thanked for H. canariense material. The Austrian Science Foundation (FWF) is sincerely thanked for their financial
support (Project M844-B05).
References: [1] Ernst, E. (Ed.) (2003) Hypericum: The Genus Hypericum, Taylor & Francis, London/New
York.